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Objective. Experience sampling assessments (multiple assessments per day for
approximately one week) indicate that positive symptoms fluctuate over time in
psychosis. Precursors, such as sleep problems or worrying, predict these fluctuations. To
date, it remains unclear whether the same precursors predict symptom variability also
during treatment in an online intervention for psychosis, using assessments lying
temporally further apart.
Methods. Participants completed brief intermediate online self-report assessments on
their computers (up to every 7 days during a 2-month waiting period and up to twice
every 6 days during a 2-month intervention period) within a randomized controlled trial.
We monitored the course of paranoia, auditory verbal hallucinations, and their theory-
driven precursors worrying, negative affect, self-esteem, self-reported cognitive biases,
and quality of sleep in n = 124 participants (M = 10.32 assessments per participant;
SD = 6.07). We tested group differences regarding the course of the composite of
precursors, group differences regarding the effect of the composite on subsequent
momentary psychotic symptoms, and the effect of each individual precursor on
subsequent psychotic symptoms, using (lagged) linear mixed models.
Results. The course composite precursors over time and their lagged effect on
subsequent momentary psychotic symptoms did not differ between groups. During the
intervention, increased worrying and decreased quality of sleep preceded heightened
momentary psychotic symptoms.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited.




Conclusion. The regression-based design does not allow drawing causal conclusions.
However, worrying and sleep problems likely represent underlying mechanisms of
psychotic symptom variability during online psychosis treatment, indicating that
experience sampling findings from everyday life generalize to interventions with
assessments lying several days apart.
Practitioner points
! Worrying and sleep problems represent important mechanisms of symptom fluctuations during an
online intervention for people with psychosis.
! Our findings further support the notion that worrying and sleep problems are important treatment
targets in psychological interventions for people with psychosis.
! Momentary levels of worrying and quality of sleep can signal subsequent fluctuations of psychotic
symptom severity so practitioners should monitor these variables during treatment.
! Worrying seems to predict subsequent paranoia specifically during treatment whereas quality of sleep
predicts both paranoia and auditory verbal hallucinations
The experience sampling method (ESM; Myin-Germeys et al., 2009) has shed light on the
temporal dynamics of positive symptoms in people with psychosis. In ESM studies on
psychosis, participants report momentary psychotic symptoms and hypothesized
correlates in diary-like self-report assessments repeatedly throughout the day. The
longitudinal data enable researchers to predict momentary psychotic symptoms through
precursors measured at a previous point in time. Precursors encompass worry and
rumination (Hartley, Haddock, Vasconcelos, Emsley, & Barrowclough, 2014), sleep
problems (e.g., Kasanova, Hajduk, Thewissen, & Myin-Germeys, 2019; Mulligan,
Haddock, Emsley, Neil, & Kyle, 2016), and low self-esteem, defined as negative views
about the self, such as being ashamed of oneself (Udachina, Varese, Myin-Germeys, &
Bentall, 2014). The ‘jumping to conclusions’ bias (Dudley, Taylor, Wickham, & Hutton,
2016) precedes subsequent momentary paranoia as well (L!udtke, Kriston, Schr!oder,
Lincoln, & Moritz, 2017). One of the most consistently found precursors of paranoia is
negative affect, a term comprising states such as feeling low, anxious, or lonely (Ben-Zeev,
Ellington, Swendsen, & Granholm, 2011; L!udtke et al., 2017; So et al., 2018). Of note, the
association of depression and paranoia seems to rely on the assessment frequency. When
measured weeks apart, paranoia predicts depression rather than vice versa (Moritz,
Goritz, McLean,Westermann, & Brodbeck, 2017; Moritz et al., 2019). In sum, ESM studies
have identified several time-variant precursors of psychotic symptoms in everyday life of
people with psychosis.
Although ESM studies do not allow drawing causal conclusions, theoretical models
(Freeman & Garety, 2014) and experimental findings (e.g., Reeve, Emsley, Sheaves, &
Freeman, 2018) indicate causal relationships between aforementioned precursors and
psychotic symptoms. Hence, it appears promising to target precursors of psychotic
symptoms in therapeutic interventions, especially because the treatment of symptom
precursors seems to coincide well with wishes and needs of participants (Freeman,
Taylor, Molodynski, & Waite, 2019; Moritz, Berna, Jaeger, Westermann, & Nagel, 2017).
There is initial support for the efficacy of interventions that focus on precursors to alter
psychotic symptoms indirectly. For example, Freeman, Dunn, et al. (2015) examined a
brief intervention based on cognitive behavioural therapy (CBT) targeting worry. The
intervention led to decreased persecutory delusions in people with non-affective
psychosis with changes in worry mediating the effect. Findings are less consistent for
sleep problems. One trial found that a sleep intervention reduced insomnia, paranoia, and
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hallucinations in healthy participants, with insomnia mediating the effect on psychotic
symptoms (Freeman et al., 2017). In clinical samples, CBT-based sleep interventions
likewise improved sleep but not psychotic symptoms (Freeman, Waite, et al., 2015;
Hwang, Nam,& Lee, 2019). It is important to note that psychotic symptoms only served as
secondary outcomes in these trials. Hence, the effect of sleep interventions on psychotic
symptoms has not yet been adequately tested. CBT-based interventions targeting
depression, a key component of the precursor negative affect, are rare (Upthegrove,
Marwaha, & Birchwood, 2017). In one trial, a CBT-based online intervention targeting
depression improved depressive but not positive symptoms (Moritz et al., 2016).
Metacognitive training (Moritz & Woodward, 2007) aims at reducing, inter alia,
participants’ proneness to cognitive biases, which served as a symptom precursor in
one ESM study aswell (L!udtke et al., 2017). Onemeta-analysis yieldedmixed findings (van
Oosterhout et al., 2016), but the majority of meta-analyses suggest that the metacognitive
training improves psychotic symptoms (Eichner & Berna, 2016; Liu, Tang, Hung, Tsai, &
Lin, 2018; Philipp et al., 2019). Taken together, treating precursors of psychotic
symptoms can be beneficial for people with psychosis.
Targeting precursors of psychotic symptoms online
Based on aforementioned studies, Westermann et al. (2020) have developed a
psychological online intervention (EviBaS) targeting not only psychotic symptoms but
also potential precursors of psychosis in guided self-help modules. The authors
successfully evaluated EviBaS in a randomized controlled trial. The intervention led to a
significant reduction in a composite score of positive symptoms (Westermann et al.,
2020). As EviBaS covers the treatment of awide range of precursors, the aimof the present
study was to investigate which of the addressed precursors would predict the course of
positive symptoms during the intervention. To do so, we monitored psychotic symptom
fluctuations and their presumed precursors similar to the procedure used in ESM trials.
Assessments took place every seven days in thewaiting period andup to twice per six days
during the intervention period. We expected that within-participant changes of the
following precursors would represent underlying mechanisms of psychotic symptom
variability during the intervention: worrying, negative affect, self-esteem, self-reported
cognitive biases, and quality of sleep. Unlike the interventionist-causal model approach
(Freeman, Dunn, et al., 2015), our examination of precursors and symptomfluctuations is
observational. It enables us to testmultiple underlyingmechanisms of psychotic symptom
variability in parallel while relying on longitudinal data with a relatively high temporal
resolution. For the present analyses, we focused on the course of positive symptoms
(auditory verbal hallucinations and paranoia) for two reasons. First, the EviBaS
intervention targets positive symptoms specifically. Hence, we aimed at identifying
precursors of these symptoms throughout the intervention. Second, we selected
symptom precursors based on previous ESM studies, which uniformly examined positive
symptoms of psychosis (e.g., Hartley et al., 2014; So et al., 2018; Udachina et al., 2014).
Aims of the study
The design enabled us to examine several research questions. First, the longitudinal
assessments allowedus tomonitor the course of precursors over time thus offering insight
into moment-to-moment effects of the EviBaS intervention beyond its already established
effect on composite positive symptoms (Westermann et al., 2020). Second, wewere able
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to examine which mechanisms of psychotic symptom fluctuations occurred during the
online intervention. The intervention aimed to ameliorate numerous candidate precur-
sors so itwas interesting to examinewhich of these candidates served as actual precursors
(i.e., mechanisms of change) of subsequent symptoms, representing variables that are
worth monitoring during treatment. Our approach focused on within-participant effects
to obtain amore idiographic view, which researchers have called for in psychological and
psychotherapy research (Piccirillo&Rodebaugh, 2019). Thewithin-participant approach
goes beyond traditional assessments of treatment mechanisms (e.g., group-based
mediation analyses) as it uncovers processes within participants over time. To our
knowledge, this is the first study to examine within-participant moment-to-moment
effects of potential mechanisms of change during an online intervention for psychosis.
Third, our analyses provide insights regarding the generalizability of ESM findings to other
contexts. Usually, ESM studies examineprecursors and outcomes several times per day for
a short period, such as one week (e.g., So et al., 2018). The rationale of ESM studies is that
within-day associations between symptoms and preceding variables can improve our
general understanding of the phenomenology and aetiology of psychopathology (Myin-
Germeys et al., 2018). We hypothesized that within-day ESM processes could represent
micro-level equivalents of larger-scale mechanisms of symptom fluctuations. To illustrate,
momentary levels ofworrying vary throughout the day andprecede subsequent psychotic
symptoms (Hartley et al., 2014). At the same time,worry as a response to a physical assault
predicts paranoia four weeks later (Freeman, Thompson, et al., 2013). The underlying
process is the same in both cases in that increasedworry precedes psychotic symptoms. It
is appealing to assume that within-day associations generalize to other contexts as this
implies that ESM studies can generate knowledge about larger-scale processes, such as the
prediction of relapse or the prediction of symptomatic improvements during treatment,
as examined here. In the present study, we tested this assumption by applying the ESM
methodology of precursor-symptom associations to an eight-week assessment period (the
assessmentswere several days apart). In addition, the randomized controlled design of the
EviBaS trial enabled us to compare associations between precursors and psychotic
symptoms in different contexts, namely awaiting condition (i.e., comparable to usual ESM
studies) and a treatment condition. We expected that precursors would improve due to
the intervention in the treatment condition whereas we expected precursors to fluctuate
naturally over time in the waitlist condition. By comparing these conditions, we could
investigatewhether precursors influence subsequent symptoms only if they vary naturally
(as in typical ESM studies) or also when they vary due to a psychological treatment.
We hypothesized that precursors would improve more in the treatment (i.e.,
immediate access) group compared to thewaitlist (i.e., delayed access) group (hypothesis
1), that precursors would predict subsequent psychotic symptoms differently in the two
groups (hypothesis 2), and that each individual precursor would predict subsequent
psychotic symptoms during participation in the EviBaS intervention across groups
(hypothesis 3).
Methods
The study is a registered (https://osf.io/gn8u5) secondary analysis of intermediate
assessment data obtained from the EviBaS trial. For results of the main trial, see
Westermann et al. (2020). The EviBaS main trial is a pre-registered (NCT02974400,
clinicaltrials.gov) multi-centre parallel-group assessor-blind randomized controlled trial
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with an allocation ratio of 1:1 evaluating the feasibility and efficacy of a CBT-based
psychological online intervention (EviBaS) for people with psychosis. The intervention
was guided, meaning that trained and supervised study staff with at least a bachelor’s
degree in psychology assisted participants using a secure messaging system. The EviBaS
intervention encompassed 11modules in total – one introductorymodule, onemodule on
relapse prevention and nine modules targeting persecutory delusions, auditory verbal
hallucinations, as well as a list of correlates of psychosis, namely worrying, low levels of
mindfulness, poor social competence, low self-esteem, depression, sleep problems, and
cognitive biases. The intervention’s approach was twofold. It addressed psychotic
symptoms directly by providing psychological models that explain hallucinations and
feelings of persecutionwhile offering exercises to decrease the participant’s burden (two
modules). On the other hand, the intervention targeted potential precursors of psychosis
in order to ameliorate symptoms indirectly (seven modules).
Out of the 11 modules only the introductory module that introduced general CBT
concepts, such as the ABC protocol (i.e., activating event, belief, consequences), and the
final module on relapse prevention were mandatory. The nine remaining modules were
not mandatory and participants could choose the order in which they completed them.
Modules contained educational components and exercises conveyed via text, audio, and
video files. At the beginning of a module, the texts, illustrations, or video files introduced
the module’s respective topic usually accompanied by a fictitious case example. Then a
CBT-based model explained associations with psychotic symptoms and offered ‘leverage
points’ for interventions. In the following, the module introduced specific interventions
(e.g., CBT-based advice on how to improve sleep, such as avoiding meals before going to
bed, addressing thoughts that compromise sleep using ABC protocols, or practicing
relaxation exercises). Most modules contained worksheets so that participants filled in
their own experiences to customize exercises. The module’s final page summarized the
main points and offered the possibility to give feedback to the guide. Completing a typical
module took approximately 30 to 60 minutes. To promote participants’ sense of
autonomy we did not require participants to complete all modules. Instead, we
considered the completion of eight modules over eight weeks as full adherence.
Trial design
At baseline, participants completed a self-report online assessment as well as a diagnostic
interview via telephone. After confirming the inclusion criteria, we used a web-based
randomization tool (based on random.org, RRID: SCR_008544) to allocate participants to
the ‘delayed access group’ or the ‘immediate access group’. We use these terms because
waitlist participants received delayed access to the intervention after the waiting period
whereas intervention groupparticipants received immediate access. After eightweekswe
invited all participants to complete a second self-report online assessment (post-
assessment).
Here, we report data from intermediate assessments that we conducted throughout
the EviBaS trial, both during thewaiting and the intervention period tomonitor the course
of symptoms and presumed precursors. While using EviBaS, participants completed the
assessments whenever they logged in, up to two times in 6 days. When a participant
accessed the online intervention using an internet browser the short online questionnaire
appeared on the screen.We chose this assessment format because we hoped tominimize
the burden for participants by combining the assessments with the intervention. Delayed
access participants completed the intermediate assessments once perweek (invited via e-
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mail) throughout the eight-week period between baseline and post-assessment, and
additionally for another eight weeks after receiving access to EviBaS (identical to the
immediate access group). For analyses on precursors of momentary symptoms during the
intervention (i.e., hypothesis 3), we used data from all participants irrespective of their
initial group allocation aswewere interested in the processes during the intervention and
not in a comparison between groups (see the boxes in Figure 1 with thick outlines).
Recruitment
We recruited participants inGermany and Switzerland. Local ethics committees approved
the study (Cantonal Ethics Committee Bern, ID 03/14; German Society for Psychology, ID
SM052015_CH). We contacted potential participants from a database listing former
participants with schizophrenia spectrum diagnoses who had previously given their
consent andwe advertised the study online. Furthermore, we reached out to psychiatrists
and psychiatric institutions.
All participants provided informed consent prior to participation. Participants were
eligible if they were 18 years of age or older, had access to the Internet, showed sufficient
command of the German language, had a lifetime diagnosis of a non-affective psychotic
disorder (verified in telephone interview), and reported receiving antipsychotic
treatment or psychotherapeutic/psychiatric consultations at least monthly. A mandatory
emergency plan listed persons that participants could contact in case of an emergency.
Weexcludedparticipants if they refused to complete the emergency plan, if they reported
a diagnosis of a neurological disease, if they displayed acute suicidality, or an acute danger
towards others.
For the present secondary analysis, we analysed data from EviBaS participants and
additional data from participants who were not part of the EviBaS main trial because they
did not meet the positive symptom severity threshold (a PANSS score of 3 or higher on at
least one of the following items: delusions, hallucinations, or suspiciousness / persecutory
delusions). These ‘secondary track’ participants completed the trial the same as the main
trial participants but with two differences, as depicted on the right-hand side of Figure 1.
First, secondary track participants did not complete a telephone interview at post-
assessment (which was irrelevant for the present analyses). Second, delayed access
participants in the secondary track had to wait 4 months to receive access to the
intervention whereas the delayed access participants of the main trial received access
directly after completing the post-assessment. The proportion of secondary track
participants was equal in the immediate access group and delayed access group (see
Table 1).
Measures
We only describe relevant measures. For a description of all measures included in the
EviBaS trial, see R!uegg et al. (2018).
Baseline measures
We report participants’ cumulated antipsychotic dosages, indicating the percentage of
the maximum dosage of a certain drug because chlorpromazine equivalents have faced
criticism (Danivas & Venkatasubramanian, 2013). We administered an adapted version of
the Mini International Neuropsychiatric Interview (MINI; Lecrubier et al., 1997) to verify
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relevant psychiatric diagnoses and the Positive andNegative Syndrome Scale (PANSS;Kay,
Fiszbein, & Opler, 1987) to measure psychotic symptom severity. The PANSS showed
good internal consistency in our sample (a = .85). We administered PANSS and MINI via
telephone.
Intermediate assessments
Participants completed a 14-item intermediate assessment questionnaire up to once per
week during the waiting period and up to two times in six days during the intervention
period. Two items (a = .42) captured psychotic symptoms, ‘I feel suspicious’, adapted
fromprevious ESM trials (Kramer et al., 2014; So et al., 2018) and ‘I hear voices that no one
else can hear’, which was self-generated. We assessed worry with the item ‘My worries
overwhelm me’, adapted from the Penn State Worry Questionnaire-Past Week (Stober &
Bittencourt, 1998). Wemeasured negative affect using two items (a = .80). The first item
‘I am feeling down, depressed, or hopeless’ stems from the Patient HealthQuestionnaire-9
(Kroenke, Spitzer, & Williams, 2001). We adopted the second item ‘I feel anxious’ from
previous ESM trials (Kasanova et al., 2019; Kramer et al., 2014). We assessed self-esteem
using the reverse-coded item ‘I am satisfiedwithmyself’ adapted from the Rosenberg Self-
Esteem scale (Rosenberg, 1965). We included two items to assess self-reported cognitive
biases. The item ‘When I am certain about something then Imust be correct’ was inspired
Table 1. Sample characteristics at baseline (N = 124)
Characteristics
Delayed
access (n = 66)
Immediate
access (n = 58) Statistics
Demographics
Age in years, mean (SD) 40.88 (9.84) 42.34 (10.85) t (122) = 0.789, p = .432
Gender (female/male) 37/29 38/20 v2 (1) = 1.155, p = .282
Years of education,
mean (SD)




18 (27%) 15 (26%) v2 (1) = 0.031, p = .859
Diagnosis of current
psychotic episode (%)
23 (35%) 28 (48%) v2 (1) = 2.299, p = .129
Diagnosis of current
depressive episode (%)
17 (26%) 20 (34%) v2 (1) = 1.123, p = .289
Reported taking antipsychotic
medication (%)
59 (89%) 47 (81%) v2 (1) = 1.738, p = .187
Cumulated antipsychotic
dosage, mean (SD)
42.19 (37.87) 34.58 (36.22) t (117) = 1.116, p = .267
PANSS total score,
mean (SD)
50.47 (13.53) 51.67 (14.95) t (122) = 0.469, p = .640
Note. SD = Standard Deviation; Secondary track participants = number of participants who were not
part of the EviBaSmain trial because they did notmeet the positive symptom severity threshold (a PANSS
score of 3 or higher on at least one of the following items: delusions, hallucinations, or suspiciousness/
persecutory delusions); diagnoses were assessed using the MINI; all participants had a diagnosis of a
previous psychotic episode; cumulated antipsychotic dosage refers to the percentage of the maximum
dosage of the antipsychotic drugs that a participant received (not all participants provided information,
hence the smaller df).
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EviBaS main trial  
(above positive symptom severity threshold) 
(n = 101) 
Secondary track  
(below positive symptom severity threshold) 
(n = 38)
Not eligible 
- No MINI psychotic disorder (n = 2) 
- No intermediate assessment (n = 8) 
Delayed access
(n = 48) 
Immediate access
(n = 43) 
Delayed access
(n = 18) 
Immediate access  
(n = 15) 
Intermediate 
assessments 
Once per week  
(Invited via e-mail) 
307 assessments,  
min = 1, max = 8 
M = 6.40 (SD = 1.69), 
Median = 7 
Intermediate 
assessments 
Up to twice/ 6 days  
(at EviBaS login)  
352 assessments,  
min = 1, max = 18 
M = 8.19 (SD = 5.15), 
Median = 7 
Intermediate 
assessments 
Once per week  
(Invited via e-mail) 
111 assessments,  
min = 1, max = 8 
M = 6.17 (SD = 1.69), 
Median = 7 
Intermediate 
assessments 
Up to twice/ 6 days  
(at EviBaS login)  
132 assessments,  
min = 1, max = 15 
M = 8.80 (SD = 4.44), 
Median = 10 
Post assessment (incl. telephone interview) Post assessment (excl. telephone interview)
4-month waiting period for delayed access participants 
including 2 further self-report assessments 
Delayed access 
group receives 
EviBaS (n = 36) 
Intermediate 
assessments 
Up to twice/ 6 days  
(at EviBaS login)  
266 assessments, 
min = 1, max = 18 
M = 7.39 (SD = 4.97), 
Median = 6.5 
Delayed access 
group receives 
EviBaS (n = 11) 
Intermediate 
assessments 
Up to twice/ 6 days  
(at EviBaS login)  
112 assessments,  
min = 1, max = 18 
M = 10.18 (SD = 6.05), 
Median = 11 
Did not provide further intermediate 
assessments (n = 12) 
Did not provide further intermediate 
assessments (n = 7) 
Not eligible 
- No intermediate assessment (n = 5) 
Randomized eligible participants (n = 33) Randomized eligible participants (n = 91) 
Participants with schizophrenia spectrum diagnoses (n = 139) completed the baseline assessment 
(online assessment and telephone interview) 
Figure 1. Flow chart (thick outlines highlight intermediate assessments used for hypothesis 3).
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by the Beck Cognitive Insight Scale (Beck, Baruch, Balter, Steer, & Warman, 2004). The
reverse-coded item ‘I consider as much information as possible before I make a decision’
aimed at assessing hasty data gathering. The items correlated negatively (after transform-
ing the reverse-coded item), so that we analysed the items separately instead of using the
scale (r = ".277). We assessed quality of sleep with the item ‘The quality of my sleep is
good’. We chose this unspecific wording to capture different types of sleep problems
(Kasanova et al., 2019). The remaining items of the intermediate assessments were not
relevant for thepresent analyses. Except for sleep, participants rated all items according to
how they felt at the current moment. For analyses of hypotheses 1 and 2, we calculated a
composite score of precursors defined as the sum of worry, negative affect, self-esteem,
self-reported cognitive biases, and quality of sleep (a = .60). The rationale of the
composite score was to reduce the overall number of confirmatory analyses to maintain
sufficient power.
Statistical analyses
We registered analyses prior to accessing the relevant data (https://osf.io/gn8u5). All
analyses represent variants of linear mixed models. Mixed models allow accounting for
the ‘nested’ structure of measurements clustered within participants, which is charac-
teristic for longitudinal data. We did not imputemissing values becausemixedmodels are
flexible in handling missing data (Twisk, 2019, p. 150).
For hypothesis 1 we tested whether the composite score of precursors (worry,
negative affect, self-esteem, self-reported cognitive biases, and quality of sleep)
improved more in the immediate access group compared to the delayed access group.
The analysis relied on intermediate assessment data obtained between baseline and
post-assessment. The statistical model included time, group (immediate vs. delayed
access), and the time x group interaction. The composite score of precursors served
as the outcome. Intermediate assessments took place at different points in time
during the intervention compared to the waiting period (upon EviBaS login vs. once
per week). To obtain a comparable number of assessments in both groups, we
aggregated the assessments by averaging the respective outcome scores from the
same week, resulting in one outcome value per week per participant. We aggregated
scores only for hypothesis 1.
For hypothesis 2, we examined if the composite score of precursors (t-1) predicted
subsequent psychotic symptoms (t0) differently in the two groups (immediate vs. delayed
access). As for hypothesis 1, we only considered data from the first eight weeks. We
conducted a lagged linear mixed model analysis with momentary psychotic symptoms
(t0) as the outcome, the composite score of precursors (t-1), group (immediate vs. delayed
access), and the group x composite score (t-1) interaction as predictors, controlling for
psychotic symptoms at t-1.
For hypothesis 3, we examined if each individual precursor predicted subsequent
psychotic symptoms during the EviBaS intervention.We conducted separate lagged linear
mixedmodel analyses with each precursor (t-1) as the predictor variable (e.g., worry) and
momentary psychotic symptoms as the outcome, while controlling for previous
psychotic symptoms (t-1). We considered data from all participants taking part in the
intervention, both immediate access participants and delayed access participants. As the
reliability analysis revealed a negative correlation between the two self-reported cognitive
bias items, we excluded the scale from the analyses for hypothesis 3 and examined the
items separately in exploratory analyses. This was a deviation from the analysis plan.
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All models included a random intercept but no random slope. For hypotheses 2
and 3, we person-mean-centred all time-variant predictors and covariates to obtain
within-participant effects rather than between-participant effects. We calculated the
within-participant mean and subtracted it from each value. One unforeseen issue was
the distance between two consecutive measurements in lagged analyses (hypotheses
2 and 3). During the intervention, it was possible that two assessments from the same
participant took place only minutes but also several weeks apart. Post hoc we set the
minimum distance between two consecutive measurements to 24 hours because we
expected the underlying mechanisms of symptom variability to require at least
24 hours to take place. We defined the upper limit as 252 hours (approximately
1.5 weeks) so that it would overlap with the one-week interval in the waiting period.
If a value lied outside the range of 24 to 252 hours, we defined it as missing in lagged
analyses (8.3%).
We used two-sided tests and conventional p-values of .05. We applied the Benjamini
and Hochberg correction to control for the false discovery rate due to multiple tests
(Benjamini & Hochberg, 1995). We conducted separate corrections for analyses 1 and 2
(two tests) and for analyses 3a to 3d (four tests). We used SPSS 25! (RRID: SCR_002865).
Results
Sample characteristics and adherence
Table 1 displays sample characteristics at baseline. Participants provided 1,280 data
points in total. Each participant completed M = 10.32 (SD = 6.07) intermediate
assessments on average (range = 1 to 25; median = 9.5). The aggregated data set that
we used to compare the course of precursors between groups throughout the first eight
weeks of the trial consisted of 600 assessments (hypothesis 1). With PANSS total scores of
roughly 50, participants were mildly ill (Leucht et al., 2005). Ordered completion rates of
EviBaSmodules for thewhole sample (n = 124) were as follows: Introduction (72%), self-
esteem (43%), social competence (39%), mindfulness (36%), cognitive biases (35%),
depression (34%), auditory hallucinations (32%), worrying (32%), persecutory delusions
(30%), relapse (30%), and sleep (30%).
Hypothesis tests
Group comparisons
For hypothesis 1, we examined if using the EviBaS intervention led to an improvement of
composite precursors (i.e., a sum score of negative affect, worrying, etc.) over time. We
used aggregated intermediate assessment data from the first eight weeks of the trial to
compare the temporal course between groups. Contrary to our hypothesis the group x
time interactionwas non-significant, indicating that the course of precursors over time did
not differ between groups (b = "0.043, SE = .096, t = 0.449, p = .653). Hence the
intervention did not improve the composite score of precursors compared to the waitlist
condition. In fact, themain effect of timewas non-significant both in the immediate access
group (b = "0.001, SE = .069, t = 0.013, p = .989) and the delayed access group (b =
0.041, SE = .067, t = 0.613, p = .540), indicating that – across groups – precursors did
not improve. For hypothesis 2 we examined if the composite score of precursors
predicted subsequent momentary psychotic symptoms differently in the immediate
access group compared to the delayed access group. The group x composite precursors
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interaction was non-significant, indicating that the composite score of precursors did not
predict subsequent momentary psychotic symptoms differently in the two groups (b =
0.031, SE = .032, t = 0.945, p = .345).
Analyses within the intervention (across groups)
For hypotheses 3we conducted separate analyses to evaluate if each individual precursor
(worry, negative affect, self-esteem, and quality of sleep) predicted subsequent
momentary psychotic symptoms within the intervention only. We used data from all
participants who completed intermediate assessments while using EviBaS irrespective of
their initial group allocation. Please note that we conducted the analyses despite the
insufficient internal consistency of the psychotic symptom scale because we wanted to
adhere to the registered analysis plan.We addressed the problem in exploratory analyses,
in whichwe analysed paranoia and auditory hallucinations as separate outcomes. Table 2
displays the model coefficients for each precursor. The effects of worry and quality of
sleep on subsequentmomentary psychotic symptoms remained significant after applying
the Benjamini andHochberg correction. The results indicate thatmoremomentaryworry,
compared to a participant’s average level of worrying, preceded more momentary
psychotic symptoms at the following intermediate assessment throughout the interven-
tion (b = 0.156, pFDR = .030). Higher momentary quality of sleep, compared to a
participant’s average quality of sleep, preceded less momentary psychotic symptoms
(b = "0.198, pFDR = .003).
Exploratory analyses
First, the self-reported cognitive bias scale consisted of two items, which correlated
negatively. Hence,we analysed each item separately to examine if it preceded subsequent
momentary psychotic symptoms in the EviBaS intervention (equivalent to analyses for
hypotheses 3). Neither item predicted subsequent momentary psychotic symptoms
(p’s ! .359). Second, the ‘psychotic symptoms’ scale (auditory verbal hallucinations and
paranoia) displayed insufficient internal consistency. Exploratory analyses with auditory
verbal hallucinations and paranoia as separate outcomes indicated that the effect ofworry
consisted mainly of an effect on paranoia (b = 0.116, SE = .044, t = 2.608, p = .009)
rather than auditory verbal hallucinations (b = 0.035, SE = .034, t = 1.031, p = .303).
Table 2. Coefficients of lagged linearmixedmodel analyseswithin participants using EviBaS intervention
(n = 105)
Precursor (t-1) Unstandardized coefficient (b) SE t p FDR
Worry 0.156 0.064 2.438 .015 .030
Negative affect 0.046 0.034 1.350 .177 .237
Self-esteem "0.007 0.069 0.106 .916 .916
Quality of sleep "0.198 0.059 3.359 .001 .003
Note. Outcome = momentary psychotic symptoms (t0) defined as the sum of self-reported suspicious-
ness and auditory verbal hallucinations; all precursors are participant-mean-centred; all models contain
participant-mean-centred psychotic symptoms at t-1 as covariates; wedonot present coefficients for self-
reported cognitive biases because of the scale’s inconsistency; SE = Standard Error; FDR = False
Discovery Rate-corrected values based on 4 tests, according to Benjamini and Hochberg (1995).
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Quality of sleepprecededbothparanoia (b = "0.104, SE = .041, t = 2.529,p = .012) and
auditory verbal hallucinations (b = "0.087, SE = .032, t = 2.736, p = .006). Negative
affect, which failed to predict composite psychotic symptoms, predicted paranoia (b =
0.058, SE = .023, t = 2.484, p = .013), while there was no effect on auditory verbal
hallucinations (b = "0.011, SE = .017, t = 0.651, p = .516). Third, we addressed the
poor internal consistency of the composite score of precursors (negative affect, worry,
self-esteem, self-reported cognitive biases, and quality of sleep). Note thatwe summarized
these precursors to reduce the number of confirmatory tests and we did expect poor
internal consistency. We repeated the analyses using single precursors instead of the
composite score in separate models. No group x time interactions reached significance
(all p’s ! .411) replicating our initial findings that group allocation did not affect the
course of precursors. Following up hypothesis 2, we examined if each individual
precursor (instead of the composite score) preceded subsequent momentary psychotic
symptoms differently when compared between groups (immediate vs. delayed access).
None of the group x precursor interactions reached significance (all p’s ! .084),
replicating our initial findings that the effect of precursors on subsequent psychotic
symptoms did not differ between groups.
Discussion
We conducted registered longitudinal mixed model analyses on data obtained from a
randomized controlled trial (R!uegg, Moritz, Berger, L!udtke, & Westermann, 2018) and a
secondary track of the trial to identify mechanisms of psychotic symptom fluctuations
during a psychological online intervention for people with psychosis. By analysing brief
intermediate assessments, we were able to compare the course of presumed symptom
precursors (worry, negative affect, self-esteem, self-reported cognitive biases, and quality
of sleep) between groups, and to examine each precursor’s association with subsequent
psychotic symptoms. There were no group differences, neither regarding the course of
precursors, nor regarding their effect on subsequent psychotic symptoms. However,
during the EviBaS intervention we found that momentary worry and quality of sleep
predicted subsequent psychotic symptoms (auditory verbal hallucinations and paranoia)
across the entire sample.When participants experiencedmoreworry orworse sleep than
usualwhile using the EviBaS intervention, they reportedmore severepsychotic symptoms
upon the next assessment. Exploratory analyses with separate outcomes (due to the poor
internal consistency of psychotic symptoms) replicated these findings, showing that
fluctuations of quality of sleep preceded both auditory hallucinations and paranoia
whereas fluctuations of worry preceded paranoia. Within-participant effects during the
intervention in the absence of group effects indicate that the intervention did not improve
worry or quality of sleep consistently and persistently across participants, but when
fluctuations ofworry or quality of sleepoccurred, these fluctuations preceded subsequent
symptoms. We cannot make the causal inference that worry or sleep led to momentary
psychotic symptoms during the intervention. Further, we cannot conclude that the
effectiveness of the EviBaS intervention relied on its capacity to reduce worry or sleep
problems. We can gain confidence, though, that worry and quality of sleep represent
important mechanisms of symptom fluctuations and hence treatment targets in
interventions for people with psychosis. It seems worthwhile to monitor worrying and
quality of sleep during treatment as these variables could indicate upcoming change of
psychotic symptoms. Interestingly, themodules addressing worrying and sleep problems
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had lower completion rates compared to other modules of the intervention. It is possible
that this finding hints at a discrepancy between the importance of these variables as
symptom precursors and their perceived importance by patients (and or perceived
changeability).
The effects of worry and quality of sleep on psychotic symptoms occurred although
assessments were several days apart over a period of 8 weeks. Hence, one can speculate
thatworry andquality of sleep, establishedprecursors inprevious ESM trials (Hartley et al.,
2014; Kasanova et al., 2019), generalize to longer assessment periods. This finding can
help to expand our knowledge about the temporal reach of ESM effects. Whereas effects
of momentary negative affect or momentary self-esteem could be limited to few hours,
worrying and sleep problems could be candidate processes in the prediction of events
lying further away, such as relapse or treatment response.
The absence of group differences regarding the course of composite precursors over
time was unexpected given the intervention’s focus on improving these precursors. This
null resultwas particularly surprising in the light of the intervention’s overall effectiveness
in the reduction of positive symptoms of psychosis (Westermann et al., 2020). Onemight
argue that the intervention’s effect on psychotic symptoms was hence independent of
within-participant improvements of precursor symptoms, which would partly contradict
the rationale of the intervention. Possibly, the intervention’s efficacy mainly relied on
directly targeting psychotic symptoms.
Another unexpected finding was that neither negative affect, nor self-esteem, nor self-
reported cognitive biases served as precursors of subsequent psychotic symptoms during
the intervention despite beingwell-established precursors of psychotic symptoms in ESM
studies (L!udtke et al., 2017; So et al., 2018; Udachina et al., 2014). The null effect of self-
reported cognitive biases on subsequent psychotic symptoms should be interpreted with
great caution as our two-item self-report scale was not internally consistent. However,
even if it had been, the scale would nonetheless differ from experimental paradigms such
as the beads task (Ross, McKay, Coltheart, & Langdon, 2015). Even established self-report
scales show no correlation (CBQp; Peters et al., 2014) or only moderate correlation with
the beads task (DACOBS; van der Gaag et al., 2013). This inconsistency of self-report and
objective measures could be due to the lack of metacognitive awareness of cognitive
deficits and biases in psychosis (Peters et al., 2014). An alternative explanation would be
that certain experimental tasks measure something other than self-report scales as
indicated by research onobjective versus subjective effort in schizophrenia (Kreis,Moritz,
& Pfuhl, 2020).
The non-significant association of negative affect with subsequent psychotic symp-
tomswas surprising aswell, considering the body of research consistently showing lagged
effects of negative affect on psychotic symptoms within the same day (Ben-Zeev et al.,
2011; L!udtke et al., 2017; So et al., 2018). This finding is again subject to caution due to the
insufficient internal consistency of the outcome variable ‘psychotic symptoms’.
Exploratory analyses indicated that negative affect might predict paranoia but not
auditory verbal hallucinations, which coincides with findings that negative affect relates
to paranoid thinking specifically (Freeman, Dunn, et al., 2013). Despite this methodolog-
ical concern, it is possible that current negative affect influences psychotic symptoms
only within the same day – not across several days. This interpretation fits the empirical
finding that negative emotions fluctuate intensely throughout the day in people with
psychosis (Myin-Germeys, Delespaul, & deVries, 2000). Consequently, effects on
subsequent psychotic symptoms are likely to be short-term and transient due to the
temporal variability of negative affect. In contrast, worry could be more stable, meaning
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that it fluctuates at a slower rate thus making it a better precursor of treatment progress
during interventions such as EviBaS. Conceptually, worrying represents both a momen-
tary action as well as a more trait-like thinking style (i.e., a ‘worry thinking style’; Freeman
& Garety, 2014). This could explain why worrying functions as a precursor both of
psychotic symptoms within the same day (Hartley et al., 2014) and of symptom
fluctuations during treatment assessed several days later.
Finally, momentary self-esteem did not precede psychotic symptoms, contradicting
findings by Udachina et al. (2014). Comparable to negative affect, momentary self-esteem
could be highly unstable in peoplewith psychosis as suggested by the revisedAttribution–
Self-Representation Cycle model of paranoia (as reviewed by Murphy, Bentall, Freeman,
O’Rourke, & Hutton, 2018), which would predict only short-term associations with
subsequent symptoms. The model proposes that instead of restoring stable self-esteem,
externalizing attributions lead to highly unstable self-esteem. Consistent with these
predictions the moment-to-moment variability of self-esteem predicts trait paranoia more
than the overall level of self-esteem (Thewissen, Bentall, Lecomte, van Os, & Myin-
Germeys, 2008). Preliminarily, our findings suggest that self-esteem is not suited as a
precursor of infrequently monitored treatment progress, possibly due to its instability
impeding far-reaching predictions.
Worry and quality of sleep as potential mechanisms of symptom fluctuations
Worry is associatedwith paranoia in experimental (Martinelli, Cavanagh, &Dudley, 2013)
and ESM trials (Hartley et al., 2014). Further, treatingworry leads to improved persecutory
delusions in people with psychosis mediated by change in worrying (Freeman, Dunn,
et al., 2015). Freeman, Dunn, et al. (2015) discuss that their mediator analysis cannot
determine the direction of associations beyond doubt. Our longitudinal design supports
the hypothesis that alterations of worry precede paranoia during psychological
interventions. Freeman, Dunn, et al. (2015) assume a causal relationship of worry with
paranoia in particular. Albeit exploratory, our results support this notion inasmuch as we
found associations of worry with subsequent paranoia only but not auditory verbal
hallucinations. From a theoretical point of view, worrying is conceptually very similar to
paranoia. As Freeman and Garety phrased it ‘worry brings implausible ideas to mind,
keeps them there, and increases the distress that they cause’ (Freeman &Garety, 2014, p.
1180).
Quality of sleepwas another significant predictor of subsequentmomentary psychotic
symptoms in our study preceding both paranoia and auditory verbal hallucinations in
exploratory analyses. As forworry,we cannot conclude that quality of sleep causally led to
subsequent symptoms but, again, we gain confidence that quality of sleep represents a
worthwhile treatment target as it indicates upcoming symptom change. This conclusion
coincides with cross-sectional (Koyanagi & Stickley, 2015), experimental (Petrovsky
et al., 2014; Reeve et al., 2018), ESM- (Kasanova et al., 2019; Mulligan et al., 2016), and
interventional trials in healthy participants (Freeman et al., 2017). So far, preliminary
clinical trials in patients have not yielded significant effects of sleep interventions on
psychotic symptoms as secondary outcomes (Freeman, Waite, et al., 2015; Hwang et al.,
2019) so that effects of sleep interventions on clinical psychotic symptoms await to be
established. How sleep contributes to psychotic symptoms is not entirely clear. Negative
affect couldmediate the effect of quality of sleep (Kasanova et al., 2019; Rehman, Gumley,
& Biello, 2018) or induced sleep loss (Reeve et al., 2018) on paranoia. Further, sleep
influences several neural processes (Krause et al., 2017) but also psychological outcomes,
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such as quality of life, emotion regulation, or cognitive functioning (Faiola et al., 2018;
Grezellschak, Jansen, & Westermann, 2017; Harvey, 2009). In sum, sleep is consistently
associated with psychotic symptoms but potential pathways are manifold and await
further elaboration.
The effects of worry and sleep on psychotic symptoms are not exclusive to people
with psychosis. Harvey (2008) describes insomnia as a transdiagnostic process, and both
worry (Bell & O’Driscoll, 2018) and sleep (Hennig & Lincoln, 2018) are associated with
paranoia in general population samples, indicating that associations betweenworry/sleep
and subclinical psychotic symptoms could be universal. Furthermore, 30% of our sample
fulfilled the criteria of a current depressive disorder, corroborating findings that comorbid
depression is highly prevalent in people with schizophrenia (Buckley, Miller, Lehrer, &
Castle, 2009). Future studies should examine whether comorbid depression moderates
the association between psychotic symptoms and worrying or quality of sleep.
Limitations
First, the regression-based design does not permit causal interpretations. Second, the
validity of the self-reported cognitive biases assessmentwas insufficient. Third, analyses in
this study were nomothetic despite appearing idiographic at first sight (Piccirillo &
Rodebaugh, 2019). Although our focus lied on within-participant effects, we examined
‘fixed effects’ across participants instead of individual symptom trajectories. Fourth, the
proportionof female participants in our sample (60%)washigher than in comparable face-
to-face psychotherapy trials for people with psychosis (e.g., 44%; Lincoln et al., 2012).
However, the unequal gender distribution is not surprising when considering that online
interventions for other disorders, such as depression, seem to attract female users
particularly (e.g., 67% female participants in Karyotaki et al., 2018). Nonetheless, the
gender distribution limits the generalizability of our findings beyond online interventions.
Conclusions
Worry and quality of sleep are potential mechanisms of symptom variability and hence
treatment targets in the context of online interventions for psychosis. While effects of
worry might be limited to paranoia, quality of sleep appears to affect auditory verbal
hallucinations as well. From a methodological point of view, our results show how
participant-mean-centred longitudinal analyses represent an informative addition to
group comparisons in randomized controlled trials. For clinicians, it seems promising to
monitor worrying and sleep problems during treatment as indicators of both positive and
negative treatment progression. Future studies should examine the effects of worrying
and quality of sleep on symptoms other than auditory hallucinations and paranoia, such as
negative symptoms.
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